Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KOEN E100 TZ is a veterinary pharmaceutical mineral salt block (lick block) developed by Nippon Zenyaku Kogyo (ZENOAQ) for ruminants and other livestock. It is specifically formulated to provide supplementation of selenium and vitamin E to prevent and treat deficiency-related diseases, such as white muscle disease (nutritional muscular dystrophy). The product is designed to be palatable, durable, and water-resistant for outdoor use, ensuring consistent intake of these essential nutrients. In Japan, it is classified as a pharmaceutical product rather than a simple feed additive, reflecting its role in disease prevention and improvement in livestock health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KOEN E100 TZ.